Ticker > IPO > New Listed IPO > Supriya Lifescience Ltd.

Supriya Lifescience Ltd. IPO

One of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients (“APIs”), with a focus on research and development. As of October 31, 2021, the company has niche product offerings of 38 APIs focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and antiallergic.

RHP
View
DRHP
View
Open Date

2021-12-16

Close Date

2021-12-20

IPO Details

Check out the issue details for Supriya Lifescience Ltd. IPO as disclosed in SEBI.

IPO Price

₹ 274

Price Band

₹ 265 - 274

Issue Size

700 Cr.

Issue Type

Book Built

Open

2021-12-16

Close

2021-12-20

Listingprice

₹ 421

ListingGain

53.65%

Listing Date

2021-12-28

CMP

₹ 409.5

Current Return

49.45%

News

Supriya Lifescience informs about disclosure24 Apr, 2:50PM Supriya Lifescience submits analyst meet intimation6 Mar, 5:02PM Supriya Lifescience informs about conference call5 Mar, 2:53PM Supriya Lifescience informs about analyst meet 5 Mar, 10:38AM Supriya Lifescience informs about disclosure 29 Feb, 10:57AM Supriya Lifescience informs about analyst meet23 Feb, 2:48PM Supriya Lifescience - Quaterly Results7 Feb, 5:44PM Supriya Lifescience - Quaterly Results7 Feb, 5:44PM Supriya Lifescience - Quaterly Results7 Feb, 5:44PM Supriya Lifescience gets GMP certification from ANVISA Brazil 5 Jan, 3:12PM Supriya Lifescience informs about trading window closure28 Dec, 12:07PM Supriya Lifescience - Quaterly Results7 Nov, 4:55PM Supriya Lifescience - Quaterly Results7 Nov, 4:55PM Supriya Lifescience collaborates with Kalinga Institute of Industrial Technology23 Oct, 3:20PM Supriya Lifescience submits analyst meet intimation26 Sep, 12:55PM Supriya Lifescience submits analyst meet14 Sep, 4:45PM Supriya Lifescience informs about analyst meet11 Sep, 11:09AM Supriya Lifescience informs about record date and book closure date5 Sep, 5:06PM Supriya Lifescience submits analyst meet intimation17 Aug, 4:43PM Supriya Lifescience informs about press release4 Aug, 10:27AM

Company Financials

You can get the following financial statements of Supriya Lifescience Ltd. as of now.

Exchange

NSE: SUPRIYA BSE: 543434

  Profit Loss
  Balance Sheet
  Quarterly
  Shareholding
  Cash Flow

Subscription Details

The details about the Supriya LifeSciences IPO is as:

  • The issue size of the IPO is 700 Cr.
  • The price band ranges from Rs 265 to Rs 274.
  • The shares of Supriya LifeSciences ltd will list on 28th December 2021.
  • The latest tentative GMP of Supriya LifeSciences IPO is Rs 150.
  • The shares of Supriya LifeSciences is subscribed 71.51 Times as of 20th December 2021.

 

Supriya LifeSciences IPO Valuation

The approx valuation of Supriya LifeSciences IPO based on its price band and DRHP/RHP is:

Particulars Value
Upper Price Band Rs 274
Existing Shares (Qty) 7.31 Cr
Fresh Issue 200  Cr
Market Cap 2202.94 Cr
EPS (FY21) Rs 16.92
PE Ratio 16.19x
Industry PE 23.02x

 

Supriya LifeSciences IPO Issue Size

Supriya LifeSciences IPO issue size is 700 Cr.

Issue Amount
Fresh Issue 200 Cr
Offer For Sale 500 Cr

 

Supriya LifeSciences IPO Market Lot

An Individual can apply for a minimum 1 lot of 54 shares and a maximum of 13 lots of 702 shares. Find the details below:

Application Lot Shares Amount
 Minimum  1 54 Rs 14,796
 Maximum 13 702 Rs 1,92,348

 

Supriya LifeSciences IPO Share Offer

The shares of Supriya LifeSciences is subscribed 71.51 Times as of 20th December 2021. The category-wise share subscription is as follows:

Category % Offered Subscription
Qualified Institutional Minimum 75% 31.83 Times
Non-Institutional Maximum 15% 161.22 Times
Retail Individual Maximum 10% 56.01 Times
Total   71.51 Times

 

Supriya LifeSciences IPO Grey Market Premium

As on GMP (Tentative)
17 December 2021 Rs 280
18 December 2021 Rs 280
19 December 2021 Rs 180
20 December 2021 Rs 180
21 December 2021 Rs 150

It is purely for informational purposes and invest in an IPO after thoroughly researching on your own.

 

Allotment Details

Find below the dates for Supriya LifeSciences IPO:

Schedule Date
Basis of Allotment 23 December 2021
Refunds 24 December 2021
Credit to Demat Account 27 December 2021
IPO Listing Date 28 December 2021

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 277.84 311.64 391.22 530.05 460.94
Total Expenditure 213.41 213.26 218.07 316.06 332.5
Operating Profit 64.43 98.38 173.15 213.98 128.44
Other Income 8.33 11.07 5.01 7.58 9.99
Interest 10.22 6.85 4.08 4.2 3.13
Depreciation 5.44 6.38 6.76 10.12 11.82
Exceptional Items 0 0 0 0 0
Profit Before Tax 57.1 96.23 167.31 207.25 123.49
Provision for Tax 17.68 22.82 43.72 55.44 33.63
Net Profit 39.42 73.4 123.59 151.81 89.86
Adjusted EPS (Rs.) 0.54 1 1.69 1.89 1.12

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 14.64 14.64 14.64 16.1 16.1
Total Reserves 79.15 134.56 253.95 599.59 683.36
Borrowings 8.14 2.39 0 0 0
Other N/C liabilities 16.22 29.46 30.86 19.38 25.04
Current liabilities 134.91 155.39 146.02 99.7 95.78
Total Liabilities 253.05 336.43 445.47 734.76 820.28
Assets
Net Block 84.68 97.99 100.04 189.77 261.54
Capital WIP 35.35 40.21 78.79 43.41 67.63
Intangible WIP 0 0 0 0 0
Investments 0.05 0.05 0.05 0.05 25.3
Loans & Advances 0.3 0.18 1.13 3.98 0.93
Other N/C Assets 0 0 0 0 0
Current Assets 132.66 197.99 265.46 497.54 464.89
Total Assets 253.05 336.43 445.47 734.76 820.28
* Other Non-current Liabilities include Net deferred Liabilities

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Other Income 2.56 1.96 2.92 2.47 3.07
Profit Before Tax 12.64 53.29 42.64 29.78 40.1
Tax 3.13 15.06 14.13 5.89 10.31
Profit After Tax 9.52 38.23 28.51 23.88 29.79
Adjusted EPS (Rs) 1.18 4.75 3.54 2.97 3.7

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2024 68.3 0
Dec 2023 68.3 0
Sep 2023 68.3 0
Jun 2023 68.3 0
Mar 2023 68.28 0
* Figures given above are % of equity capital

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 57.1 96.23 167.31 207.25 123.49
Adjustment 12.67 10.24 5.39 6.87 7.2
Changes in Assets & Liabilities -6.8 36.6 -66.82 -104.35 -35.64
Tax Paid -14.09 -27.01 -29.99 -60.96 -28.86
Operating Cash Flow 48.88 116.06 75.89 48.8 66.19
Investing Cash Flow 4.83 -24.53 -46.8 -59.82 -133.14
Financing Cash Flow -49.93 -29.23 -14.52 149.65 -3.37
Net Cash Flow 3.79 62.31 14.57 138.63 -70.32
X